Dr. Sara Rogers

Dr. Sara Rogers has a talent for making complex concepts easy to understand and engaging. Whether she is teaching clinical pharmacology at Texas A&M School of Engineering Medicine (EnMed) or spearheading innovative initiatives in precision medicine, her enthusiasm shines through. As a clinical assistant professor, she’s on a mission to prepare future physicianeers with the skills and confidence they need to positively impact patient care. 

At the beginning of her medical journey, Rogers was completely immersed in the MD Anderson Cancer Center oncology clinics, where she worked as an ambulatory treatment center pharmacist. Her early years taught her the importance of patient-centered care, the critical role of medication safety, lessons that continue to shape her work today. Motivated to tackle the widespread issue of adverse drug events, she co-founded the American Society of Pharmacovigilance, a nonprofit dedicated to making medications safer for everyone. 

At Texas A&M Health, Rogers has taken her passion for personalized care to new heights. She launched a clinical pharmacogenomics service that uses patients’ genetic information to tailor medications for better outcomes. This groundbreaking approach to healthcare shows how science can truly transform lives. Furthermore, she’s part of the Institute of Biosciences and Technology’s Center for Genomic and Precision Medicine, where she bridges lab research with practical healthcare solutions for everyday use.  

Dr. Rodgers in action
Dr. Rogers discusses the Interprofessional Pharmacogenomics (IPGx) research protocol with pharmacist interns at the Texas A&M Health Family Care Clinic.

Rogers’ influence extends beyond her local contributions and has had a national impact. She is the founder of National Adverse Drug Event Awareness Day, which is observed annually on March 2 to emphasize the importance of medication safety. This initiative earned her an invitation to a congressional briefing at the White House, where she celebrated advancements in personalized medicine alongside prominent leaders, including Eric Green, Director of the NIH National Human Genomics Research Institute and Deepak Voora, Director of the National Pharmacogenomics Program at the Department of Veteran Affairs. 

Her guiding philosophy is clear: “The past is gone, the future is uncertain, and we have only this, our hour, to live.”  This perspective emphasizes the importance of focusing on the present and encourages students to use their medical education to create meaningful change at EnMed and beyond. 

Congressional Briefing at the White House
Pictured at a congressional briefing at the White House on National Adverse Drug Event Awareness Day to celebrate advances in personalized medicine (L to R): Benjamin Brown, Eric Green, Eric Swalwell, Sara Rogers, and Deepak Voora.